Proceedings of the Ninth International Conference of Drug Regulatory Authorities (ICDRA) - Berlin, Germany 25-29 April 1999
(1999; 102 pages) Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuOpening Ceremony
Ouvrir ce répertoire et afficher son contenuGood regulatory practice
Ouvrir ce répertoire et afficher son contenuGood certification practice
Ouvrir ce répertoire et afficher son contenuCounterfeit drugs: challenges and solutions
Ouvrir ce répertoire et afficher son contenuCurrent issues in regulation and quality
Ouvrir ce répertoire et afficher son contenuInternational Conference on Harmonization: implementation and implications
Ouvrir ce répertoire et afficher son contenuDrug utilization studies
Ouvrir ce répertoire et afficher son contenuInternational Conference on Harmonization and the common technical document
Ouvrir ce répertoire et afficher son contenuKeynote address
Fermer ce répertoireGlobal and national efforts to reduce tobacco use
Afficher le documentHow national authorities can promote non-smoking: experience from a European Union country
Afficher le documentInternational implications of the regulation of nicotine products
Afficher le documentPublic health responsibilities of nicotine regulation
Afficher le documentDiscussion
Afficher le documentRecommendations
Ouvrir ce répertoire et afficher son contenuElectronic communication in the regulatory process
Ouvrir ce répertoire et afficher son contenuTransparency in monitoring the safety of medicines
Ouvrir ce répertoire et afficher son contenuPharmaceutical products for use in special groups
Ouvrir ce répertoire et afficher son contenuNeed for Bioequivalence
Ouvrir ce répertoire et afficher son contenuAntimicrobial resistance: battling the bugs
Ouvrir ce répertoire et afficher son contenuSafety issues of plasma-derived medicinal products
Ouvrir ce répertoire et afficher son contenuHerbal medicines
Ouvrir ce répertoire et afficher son contenuRegulation and access to essential drugs
Afficher le documentParticipants
Afficher le documentBack cover
 

How national authorities can promote non-smoking: experience from a European Union country

Dr T. Piha, Finland

The experience of Finland has shown that health damage due to tobacco smoking can be reduced through a comprehensive strategy.

The importance of community action against tobacco is highlighted by the fact that the mortality rate due to lung cancer peaked in many countries about lo years after such action was started. In contrast, if no action is taken the mortality rate continues to increase.

The Finnish strategy consists of three major components: prevention of starting smoking; promotion of smoke-free environments; and support to smokers wishing to quit. The successful implementation of the strategy requires health education, taxation to increase cigarette prices, restrictions on marketing of tobacco (such as a ban on all advertising and sales restrictions) and smoke-free provisions in public places and at work. Research and monitoring underpin all efforts.

For the strategy to be effective, major interventions are indispensable, such as massive information campaigns. It is also important to address the needs of all population groups and ages. Another critical requirement is to sustain the effort over a long period of time, as it often takes many years before one can observe the impact of measures. Mobilizing political support is a must for all this, and making new alliances with groups of people not previously involved in smoking prevention activities, such as drug regulators, is a way of generating political momentum.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013